| Spencer L Eagan, MD | |
|
4320 Wornall Rd, Suite 530, Kansas City, MO 64111-5941 | |
| (816) 932-7900 | |
| (816) 932-7920 |
| Full Name | Spencer L Eagan |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 18 Years |
| Location | 4320 Wornall Rd, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881785772 | NPI | - | NPPES |
| 1881785772 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 0435520 (Kansas) | Secondary |
| 208200000X | Plastic Surgery | 2012005895 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doctors Hospital Llc | Leawood, KS | Hospital |
| Saint Luke's South Hospital | Overland park, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascentist Physicians Group Llc | 9335143759 | 107 |
| Ascentist Physicians Group Llc | 9335143759 | 107 |
News Archive
Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.
A new field of research in microbiology is transforming the way scientists see fungi, bacteria and other microorganisms.
Up to 20 percent of Parkinson's disease (PD) patients and their families may confront a common but largely unrecognized challenge: the occurrence of impulse control disorders (ICDs) such as compulsive gambling, sexual behavior, eating, or spending.
A more personalized treatment for people with a type of metastatic liver cancer hepatocellular carcinoma may be possible by targeting the protein c-Met, according to Penn State College of Medicine researchers.
› Verified 5 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.
A new field of research in microbiology is transforming the way scientists see fungi, bacteria and other microorganisms.
Up to 20 percent of Parkinson's disease (PD) patients and their families may confront a common but largely unrecognized challenge: the occurrence of impulse control disorders (ICDs) such as compulsive gambling, sexual behavior, eating, or spending.
A more personalized treatment for people with a type of metastatic liver cancer hepatocellular carcinoma may be possible by targeting the protein c-Met, according to Penn State College of Medicine researchers.
› Verified 5 days ago
| Entity Name | Ascentist Physicians Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649206319 PECOS PAC ID: 9335143759 Enrollment ID: O20060826000062 |
News Archive
Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.
A new field of research in microbiology is transforming the way scientists see fungi, bacteria and other microorganisms.
Up to 20 percent of Parkinson's disease (PD) patients and their families may confront a common but largely unrecognized challenge: the occurrence of impulse control disorders (ICDs) such as compulsive gambling, sexual behavior, eating, or spending.
A more personalized treatment for people with a type of metastatic liver cancer hepatocellular carcinoma may be possible by targeting the protein c-Met, according to Penn State College of Medicine researchers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Spencer L Eagan, MD 901 E 104th St, Mailstop 400, Kansas City, MO 64131 Ph: (816) 502-8755 | Spencer L Eagan, MD 4320 Wornall Rd, Suite 530, Kansas City, MO 64111-5941 Ph: (816) 932-7900 |
News Archive
Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.
A new field of research in microbiology is transforming the way scientists see fungi, bacteria and other microorganisms.
Up to 20 percent of Parkinson's disease (PD) patients and their families may confront a common but largely unrecognized challenge: the occurrence of impulse control disorders (ICDs) such as compulsive gambling, sexual behavior, eating, or spending.
A more personalized treatment for people with a type of metastatic liver cancer hepatocellular carcinoma may be possible by targeting the protein c-Met, according to Penn State College of Medicine researchers.
› Verified 5 days ago
Satish Ponnuru, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4320 Wornall Rd, Suite 513, Kansas City, MO 64111 Phone: 816-932-4549 Fax: 816-932-5793 | |
Dr. Melvin Nathan Abend, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 848 W 52nd Ter, Pob 30568, Kansas City, MO 64112 Phone: 819-523-4800 Fax: 816-523-7756 | |
Dr. Dana R Towle, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4444 N Belleview Ave, Ste 204, Kansas City, MO 64116 Phone: 816-452-8080 Fax: 816-878-6055 | |
Mr. Michael Alexander Lypka, MD, DMD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Mr. Don G Fortin, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-0099 | |
Lindsay Elise Powers, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2101 Charlotte St, Kansas City, MO 64108 Phone: 816-876-2919 Fax: 816-876-2921 | |
Thuan Nguyen, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4320 Wornall Rd Ste 530, Kansas City, MO 64111 Phone: 816-932-0288 Fax: 816-932-9868 |